Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section

Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP

Principal Investigator

Kevin Kwaku

Study Number

F19013

Summary

The primary objective is to understand the role of antitachycardia pacing (ATP) in primary prevention patients indicated for ICD therapy and programmed according to current guidance of higher rate cut-offs and therapy delays. The time to first all-cause shock will be tested in subjects with standard therapy (ATP and shocks) compared to subjects programmed to shock only to assess equivalency.

Phase

N/A

Contact

Brian Aldrich

Available at the following location(s)

  • Lebanon

View more details at ClinicalTrials.gov

Do you need help with some of the labels on this page?
Read our glossary of terms

0